Business briefing for April 14

LanzaTech gets lowball takeover offer The ethanol technology firm LanzaTech has received a takeover offer of 2 cents per share from one of its investors, Carbon Direct Capital Management. Carbon Direct says the offer, which is at about a tenth of LanzaTech’s current stock price, may be the only thing that keeps LanzaTech from going bankrupt. LanzaTech says its partners operate six commercial facilities worldwide using its fermentation technology to convert carbon monoxide into ethanol. But the firm has been struggling. During the first 9 months of last year, it generated a loss of $110.7 million on $37.6 million in sales. In January, LanzaTech said it would spin off its synthetic biology platform. It later requested an extension for publishing its 2024 annual report. And in March, the company announced a $30 million cost reduction program that would cut 10–15% of its workforce.—alex tullo OQ is sold and becomes Oxea

Publication Details

Journal
C&EN Global Enterprise
Published
2025-04-14
DOI
https://doi.org/10.1021/cen-10310-buscon6
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Business briefing for April 14

1 links
C&EN Global Enterprise
Biotechnology and Related Fields
article

Business briefing for April 14

article en

Abstract

LanzaTech gets lowball takeover offer The ethanol technology firm LanzaTech has received a takeover offer of 2 cents per share from one of its investors, Carbon Direct Capital Management. Carbon Direct says the offer, which is at about a tenth of LanzaTech’s current stock price, may be the only thing that keeps LanzaTech from going bankrupt. LanzaTech says its partners operate six commercial facilities worldwide using its fermentation technology to convert carbon monoxide into ethanol. But the firm has been struggling. During the first 9 months of last year, it generated a loss of $110.7 million on $37.6 million in sales. In January, LanzaTech said it would spin off its synthetic biology platform. It later requested an extension for publishing its 2024 annual report. And in March, the company announced a $30 million cost reduction program that would cut 10–15% of its workforce.—alex tullo OQ is sold and becomes Oxea

C&EN Global EnterpriseVol. 103(10)
Openalex Percentile: Top 89%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.